SCHEMBL8550864

SCHEMBL8550864

O=C1CC(S(=O)(=O)Cc2ccccc2)N1Cc1nc(CCCCCc2ccccc2)cs1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.39
HDAC6 Q9UBN7 4/20 0.39
ADRB3 P13945 3/20 0.33
NOS1 P29475 1/20 0.33
PDE5A O76074 1/20 0.32
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE1C Q14123 1/20 0.32
LMNA P02545 1/20 0.32
RAB9A P51151 1/20 0.32
HCRTR1 O43613 3/20 0.32
HCRTR2 O43614 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
DRD2 P14416 1/20 0.31
HTR2A P28223 1/20 0.31
HRH1 P35367 1/20 0.31
ADAM17 P78536 1/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551143 0.79 HDAC1 (0.40) HDAC1HDAC6NOS1PDE5APDE1A
SCHEMBL8439355 0.78 GSK3A (0.44) MEN1KMT2A
SCHEMBL8550303 0.77 HDAC1 (0.39) HDAC1HDAC6ADRB3NOS1PDE5A
SCHEMBL8623161 0.75 GSK3B (0.39) MEN1KMT2A
SCHEMBL8552263 0.73 HRH1 (0.39) LMNARAB9AKMT2AHRH1
SCHEMBL8772449 0.72 CYP1A2 (0.42) LMNAMEN1KMT2AHTR2A
SCHEMBL8772454 0.72 POLB (0.42) LMNAMEN1KMT2A
SCHEMBL8442243 0.70 TRPV1 (0.49) LMNAKMT2A
SCHEMBL8549758 0.68 TRPV1 (0.44) LMNAKMT2A
SCHEMBL8551370 0.68 HDAC1 (0.51) HDAC1HDAC6NOS1PDE5APDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865429-A1 AZETIDINONE COMPOUNDS FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-09-23 EP claimed
WO-1997021676-A1 AZETIDINONE COMPOUNDS FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-06-19 WO claimed
EP-0865429-A1 AZETIDINONE COMPOUNDS FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-09-23 EP disclosed
WO-1997021676-A1 AZETIDINONE COMPOUNDS FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-06-19 WO disclosed